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Summary 
We have investigated the effect of adhesion to fibronectin (Fn) on the survival of eosinophils 
in  culture.  Peripheral  blood  eosinophils  from  normal  human  donors  were  separated  by 
immunomagnetic selection and cultured in RPMI on Fn- (100/~g/ml) coated microtiter plates 
for up to 96 h. Survival was measure1 by trypan blue exclusion. There was a significant enhancement 
of eosinophil survival with Fn as compared with both bovine serum albumin-coated and uncoated 
wells  (p <0.05-0.01).  Fn-induced eosinophil survival  was comparable to that obtained with 
exogenous interleukin 3 (IL-3) or granulocyte/macrophage colony-stimulating factor (GM-CSF) 
and was inhibitable by antibodies against Fn, very late antigen 4 (VLA-4),  IL-3, and GM-CSF. 
Supernatants from Fn-, but not BSA-coated wells contained picogram amounts of IL-3 and GM- 
CSF, and eosinophils cultured on Fn for 24 h expressed mRNA for GM-CSF as determined 
by in situ hybridization. Therefore, Fn prolongs eosinophil survival in culture by triggering autocrine 
generation of cytokines by eosinophils. Since neutrophils lack VLA-4, this could provide a partial 
explanation for the preferential  accumulation of eosinophils at sites of allergic inflammation, 
as well as the predominant tissue localization of eosinophils in healthy individuals. 
E 
osinophils are believed to be important effector cells in 
the host response to infection with helminthic parasites 
(1) and to have proinflammatory effects in allergic inflamma- 
tion, including asthma (2,  3).  In healthy individuals, eo- 
sinophils reside mainly in the tissues, but the mechanism of 
tissue localization is incompletely understood. A number of 
adhesion pathways have been defined that could potentially 
mediate the transmigration of eosinophils through the vas- 
cular endothelium. The very late antigen 4/vascular cell adhe- 
sion molecule 1 (VLA-4/VCAM-1) pathway is of particular 
interest because it is not available to neutrophils (4-7). An 
alternative mechanism for eosinophil accumulation in tissues 
is prolonged survival. Like neutrophils, eosinophils are end- 
stage cells that in culture rapidly undergo cell death. How- 
ever, eosinophil-active cytokines, such as I1.-3, I1:5, and GM- 
CSF, prolong eosinophil survival in culture for up to 2 wk 
(8, 9). They also enhance eosinophil functions such as cyto- 
toxicity for metazoan targets and mediator release (10). Acti- 
vated eosinophils can also generate a number of cytokines 
in vitro (11, 12). mRNA for cytokines such as Ib5, GM- 
CSF, and TGF-cr has also been detected in vivo in various 
disease conditions (13, 14). The physiological triggers for eo- 
sinophil cytokine generation are not dear. ExtraceUular ma- 
trix proteins have been shown to modulate eosinophil response 
to physiological soluble stimuli (15). We have recently demon- 
strated that eosinophils can adhere specifically to fibronectin 
(Fn),  an  abundant  extracellular  matrix protein,  and  that 
VLA-4, a known receptor for Fn (16), was involved in medi- 
ating eosinophil/Fn interactions (Anwar,  A. P... E., G. M. 
Walsh, O. Cromwell, A. B. Kay, and A. J. Wardlaw, manu- 
script submitted for publication). Moreover, eosinophil adhe- 
sion to Fn resulted in short-term priming of eosinophils for 
enhanced leukotriene C4 (LTC4)  release. For these reasons, 
we have studied the ability of Fn to exert longer term effects 
on eosinophil function, particularly whether it could pro- 
long eosinophil survival. 
Materials and Methods 
Reagents.  Reagents were obtained as follows. BSA (grade V), 
human plasma Fn, and the control mouse myeloma  protein MOPC 
(IgG1) were from Sigma  Chemical  Co. (Poole, UK). Micromagnetic 
beads bound to anti-CD16 mAb were obtained from Miltenyi Bio- 
Tech (Bergisch-Gladbach,  Germany).  Magnetic-activated  cell sorter 
(MACS) columns were supplied by Becton Dickinson UK, Ltd. 
(Oxford, UK). 
Antibodies.  Polyclonal  rabbit anti-human Fn was purchased  from 
CooperBiomedical, Inc. (Malvem, PA). This was shown to sig- 
nificantly inhibit adhesion of human eosinophils to Fn (Anwar et 
al., manuscript submitted for publication) and exhibited no cross- 
reactivity with other matrix proteins. Goat IgG anti-GM-CSF and 
polyclonal rabbit anti-IL-3 were purchased from British Biotech- 
nology (Oxford, UK). Both were selected  because  of their natural 
ability to neutralize the bioreactivity of their natural and recom- 
binant cytokine, i.e., IL-3 and GM-CSF, respectively.  They showed 
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a generous gift from Glaxo-Biogen  (Geneva, Switzerland). Mouse 
mAb HP2/1 (anti-CD49d, VLA-4) was a kind gift from Dr. F. 
Sanchez-Madrid (Hospital de La Princesa, Madrid, Spain). 
Eosinophil Purification.  A volume of 100 ml of blood was ob- 
tained from volunteers  with a normal eosinophil  count and without 
evidence of allergic disease. After dextran sedimentation to remove 
red blood cells a granulocyte pellet was obtained by density cen- 
trifugation on Percoll. The eosinophils were then separated from 
the neutrophils by immunomagnetic selection using the MACS 
system utilizing the observation that resting peripheral blood eo- 
sinophils, unlike neutrophils, do not express CD16 (17). In brief, 
the granulocyte  pellet was incubated (40 rain, 4~  with anti-CD16 
mAb bound to micromagnetic  beads. By negative selection,  highly 
purified CD16- eosinophils  depleted of magnetically positive neu- 
trophils  (CD16  +)  were obtained after passage of granulocytes 
through a steel wire column (MACS type B or C) held between 
a permanent magnet. This method resulted in consistently high 
recoveries (>99%)  of pure (>99%)  eosinophils. 
Eosinophil Culture.  Freshly isolated eosinophils (>99% viable 
by trypan blue exclusion), in 100/~1 of RPMI (at 2  x  10S/well), 
were cultured in 96-well flat-bottomed non-tissue culture-treated 
microtiter plates (Becton Dickinson  & Co., Lincoln  Park, NJ) coated 
with either Fn or 1% BSA, or left uncoated. To coat the wells, 
100/~1 of Fn (100 #g/ml in PBS) was added to the wells for I h 
at 37~  The plates were then washed three times with PBS to 
remove unbound protein. To block nonspecific  protein-binding  sites, 
200/zl of 1% heat-denatured BSA in PBS was added to each well, 
and the plates were incubated for 2 h at room temperature. Before 
the cells  were added, the plates were washed twice with RPMI/1% 
BSA. Eosinophils  were cultured in RPMI with penicillin  and strep- 
tomycin, but without FCS to avoid any possible interaction be- 
tween eosinophils  and matrix proteins contained in serum. In some 
experiments mAbs were added to the wells at the start of the cul- 
ture. To determine eosinophil viability, cells were removed from 
each well by gentle pipetting, stained  with trypan blue, and counted 
blindly. To confirm that all the cells had been removed from the 
well, a total cell count was performed and the well examined by 
direct vision using an inverted microscope. Endotoxin levels of Fn- 
(100/zg/ml) and BSA- (1%) treated supernatants were both <0.2 
EU/ml, as determined by the Limuhs amoebocyte lysate (LAL) 
test using the E-toxicate (LAL) kit (Sigma Chemical Co.). 
Measurement of Cytokine Generation.  Supernatants  ofeosinophils 
cultured with Fn or BSA were removed from the wells and stored 
at  -80~  until assayed. Both IL-3 and GM-CSF were measured 
using commercially available ELISA kits for IL-3 and GM-CSF 
(Quantikine; British Biotechnology, Oxford,  UK). The assay is 
an enzyme immunoassay using mouse mAbs against either IL-3 
or GM-CSF as capture antibodies, peroxidase  enzyme-linked  poly- 
clonal antibody specific  for either of the two cytokines  as the second 
antibody, and was developed by peroxide chromogenic substrate. 
The minimum detectable  concentrations  for Ib3 and GM-CSF  were 
10 and 7.5 pg/ml, respectively. 
In Situ Hybridization.  In situ hybridization was performed as 
previously  described (11, 18). Briefly,  cDNA for GM-CSF was in- 
serted into a PGEM-1 vector, linearized,  and transcribed in the pres- 
ence of 3sS-UTP and T7 and SP6 IkNA polymerases  for antisense 
(complementary RNA) and sense (having identical sequence to 
mRNA) riboprobes, respectively. Cytospins were permeabilized 
with proteinase-K. Nonspecific binding of 3ss was inhibited by 
treating the preparations with 0.1 M triethanolamine, acetic anhy- 
dride, iodoacetamide,  and N-ethylmaldeimide.  Prehybridization  was 
performed with formamide and SSC. For hybridization, antisense 
or sense probes (1-1.5  x  106 cpmAlide) were diluted in hybrid- 
ization buffer in the presence of  dithiothreitol (100 nM) and heated 
to 60~  for 1 h to block any nonspecific  binding. Hybridization 
with the riboprobes was >16 h at 40~  Posthybridization  washings 
were performed under high stringency (4-0.1x  SSC at 45-50~ 
during which unhybridized single-stranded ILNA was removed  by 
RNase-A treatment. After dehydration, cytospins were processed 
for autoradiography and counterstained with either hemotoxylin, 
or the specific eosinophil stain carbol chromotrope 2R. 
Results and Discussion 
Eosinophils cultured on Fn-coated plates had significantly 
prolonged survival when compared with cells cultured on 
plastic alone (Fig.  1) ~  <0.01 at 72 and 96 h). At 96 h, vir- 
tually all the eosinophils cultured on uncoated wells had died, 
whereas 60% of the eosinophils cultured in Fn-coated wells 
were still excluding trypan blue. Cells cultured on BSA were 
also significantly less viable at 72 and 96 h than eosinophils 
cultured on Fn (63  _+  5% vs. 32.5  _+  7%  and 47  +_  4% 
vs. 20  +  6%, respectively; p <0.05). The survival curve of 
eosinophils cultured in uncoated wells with II,-3 (10-10 M) 
(data not shown) was almost identical to that illustrated in 
Fig. 1 for eosinophils cultured in RPMI alone in Fn-coated 
wells. 
To further investigate the mechanism of prolonged Fn- 
induced eosinophil survival, we attempted to inhibit the effect 
by using a number of antibodies (Fig. 2), At 72 h, eosinophils 
cultured on Fn (Fig. 2, row I) had a viability of 63  +  5%, 
whereas eosinophils cultured in uncoated wells had a viability 
of 23  +  6.5%  (row 2; p  <0.01)  and in BSA-coated wells, 
32.5  +_  7%  (row  3;  p  <0.02).  Fn-induced survival  was 
significantly  inhibited by a polyclonal antibody that we have 
previously demonstrated inhibits eosinophil adhesion to Fn- 
coated wells (row 4; p <0.05), whereas normal rabbit serum 
had no inhibitory effect (row 5). Survival was also significantly 
inhibited by a mAb against VLA-4 (HP2/1) (row 6; p <0.05) 
but not by an isotype control antibody (data not shown). 
Lastly, survival was inhibited by antibodies against both II-3 
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Figure  1.  Survival  of eosinophils cultured on Fn-coated  wells or un- 
coated  wells. Viability  was measured  by trypan  blue exclusion  at the start 
of culture and at 48, 72, and 96 h after  culture. Fn resulted  in a significant 
prolongation of eosinophil survival  at 72 and 96 h (* p <0.01) (n ~ 5). 
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Figure  2.  Inhibition of Fn-induced eosinophil survival at 72  h.  Eo- 
sinophils were cultured on Fn (row 1), uncoated wells (row 2), or BSA 
(row 3). Eosinophils cultured on Fn had maintained survival, which was 
inhibited by an anti-Fn polyclonal antibody (row 4; p  <0.05) and anti- 
VLA-4 mAb  (row  6; p  <0.05)  and an  antibody against Ib3  (row  7; 
p <0.05). Normal rabbit serum (row 5) had no inhibitory effect. Inhibi- 
tion by an antibody against GM-CSF (row 8) was consistently detected 
but was  only significant  at 96  h  (n  =  4). 
in the supernatant of eosinophils cultured on Fn (Fig. 3 a, 
row 1; n  =  5).  In four of five experiments I1-3 could also 
be detected but in lower and more variable amounts (21-222 
pg/ml) (Fig. 3 b, row I). Negligible amounts of either GM- 
CSF (<4 pg/ml) or Ib3 (<3 pg/ml) could be detected in su- 
pernatants from BSA-coated wells (row 2). Cytokine gener- 
ation by eosinophils was effectively blocked by the anti-Fn 
antibody (row 3) and the anti-VLA-4 mAb (row 5), but not 
by normal rabbit serum (row 4) or by the isotype control 
antibody (row 6). 
To investigate if interaction with Fn induced expression 
of eosinophil cytokine mRNA, we undertook in situ hybrid- 
ization using an 3sS-labeled  riboprobe for GM-CSF using eo- 
sinophils cultured for 24 h on Fn or BSA. We chose the ear- 
lier time point because we considered that gene expression 
would precede secretion of GM-CSF. Expression of mRNA 
with antisense, but not sense, cRNA for GM-CSF was de- 
tected in eosinophils cultured on Fn but not in eosinophils 
cultured on BSA (Fig.  4). 
Eosinophils have recently  been shown to generate a number 
of cytokines, including IL-3, GM-CSF (11, 12), and Ib5 (14), 
that are active on mature eosinophils promoting, among a 
number of other responses, prolonged survival (8-10). How- 
ever, the in vivo mechanism(s) by which eosinophils are trig- 
(row 7, p <0.03) and GM-CSF (row 8), although inhibition 
by anti-GM-CSF was only significant at 96 h (p <0.02). These 
experiments demonstrated that the Fn-induced survival was 
specific, in that it was blocked by an anti-Fn polyclonal anti- 
body, but not by normal rabbit  serum, and was mediated 
by V'LA-4. Furthermore, the blocking studies with the anticy- 
tokine antibodies suggested that the mechanism for increased 
survival may involve Fu-induced release of GM-CSF and Ib3 
by eosinophils. To investigate this possibility we measured 
concentrations of I1-3 and GM-CSF in the supernatants of 
eosinophils cultured on Fn (Fig.  3).  After 48 h in culture 
between 290 and 420 pg/ml of GM-CSF could be detected 
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Figure  3.  Release of GM-CSF (a) and ID3 (b) by eosinophils cultured 
on Fn after 48 h in culture. Eosinophils released both GM-CSF and IL-3 
after culture on Fn (row I) but not after culture on BSA (row 2). Cytokine 
release was inhibited by anti-Fn (row 3) and anti-VLA-4 (row 5) antibodies 
but not by normal rabbit serum (row 4) or mouse IgG1 control (row 6) 
(.  =  5). 
Figure  4.  In situ hybridization of mKNA for GM-CSF by eosinophils 
cultured on Fn for 24 h. (A) Eosinophils hybridized with 3sS-labeled an- 
tisense riboprobe to detect GM-CSF mRNA, visualized under darkfidd 
illumination; (B) positive hybridization signals (arrows)  for GM-CSF mRNA 
colocalized to eosinophils stained specifically  with carbol chromotrope 2R; 
(C) reduced hybridization signals in Fn-cultured eosinophils in the pres- 
ence of anti-Fn antibody; (D) sense probe control. 
841  Anwar et al.  Brief Definitive Report gered to release these mediators remains unclear. In this study, 
we have demonstrated that eosinophil interaction with Fn 
induces the generation of measurable amounts of both GM- 
CSF  and Ib3,  and that  these cytokines appear  to induce 
prolonged survival of eosinophils by autocrine cytokine re- 
lease.  Therefore, eosinophils migrating into tissue in both 
healthy and diseased individuals could generate their own 
cytokines as a result of adhesion to Fn, thus preventing cell 
death and apoptosis (19). This could be one mechanism by 
which eosinophils accumulate in tissues where they primarily 
reside. We have recently demonstrated that eosinophils can 
adhere specifically to Fn and that this results in short-term 
priming of eosinophils for enhanced leukotriene C4 release 
(Anwar et al., manuscript submitted for publication). Adhe- 
sion to Fn was dependent on VLA-4, an integrin receptor 
expressed by eosinophils and mononudear cells but not by 
neutrophils. Fn-induced cytokine generation by eosinophils 
was also inhibited by an antibody against VLA-4, suggesting 
that the latter is acting as a signaling as well as an adhesion 
receptor on eosinophils. It is now well recognized that inte- 
grins can transmit signals both inside out and outside in (20). 
In addition, adherence of monocytes/macrophages was shown 
to induce transcription of GM-CSF, whereas adherence to 
collagen induced IL-1 and TNF-c, (21, 22).  This raises the 
possibility that different profiles of cytokines can be gener- 
ated by eosinophils depending on the nature of matrix pro- 
tein/integrin receptor interaction involved. Using the im- 
munomagnetic selection method of purifying eosinophils, the 
contaminating cells are usually monocytes, which, like eo- 
sinophils, do not express CD16. It is, therefore, theoretically 
possible that the cytokines could have been generated by con- 
taminating monocytes. However, the purity of the eosinophils 
in our experiments was >99%. Moreover, the in situ hybrid- 
ization experiments demonstrated GM-CSF mKNA expres- 
sion by eosinophils cultured on Fn. Eosinophils were con- 
clusively identified by the specific  eosinophil  stain  carbol 
chromatrope 2R.  The eosinophils used in this study were 
obtained from normal individuals without an eosinophilia. 
VLA-4 is constitutively expressed by eosinophils and, unlike 
Mac-l, can bind its ligands (VCAM-1 and Fn) without the 
need for cell activation (4). Nevertheless, it would be interesting 
to compare the response of eosinophils activated either in vivo 
or in vitro in both pattern and amount of cytokines rdeased 
after culture on Fn. 
We observed that eosinophils cultured in BSA had higher 
rates of survival compared with eosinophils cultured in un- 
coated wells. One explanation for this was that matrix pro- 
tein contaminants in the BSA may have been interacting with 
eosinophils resulting in the generation of  low levels of cytokines 
that though undetectable in our ELISA were nevertheless able 
to prolong survival to a limited degree. One apparent anomaly 
in the inhibition experiments described in Fig. 2 was the ability 
of the anti-IL-3  antibody to almost completely inhibit the 
Fn-induced survival.  It would be expected that only partial 
inhibition would be observed especially as more GM-CSF 
than Ib3 was detected in the supernatant at the 48-h time 
point. This may be due to the kinetics of cytokine genera- 
tion. We detected more Ib3 at 24 than at 48 h (140  _+  55 
vs. 110  +  52 pg/ml), whereas more GM-CSF was detected 
at 48 h  (92  +_  18.5 vs.  362  +_  22 pg/ml).  It is,  therefore, 
possible that the antibodies were exerting their effect in the 
early stages of the culture when Ib3 was the more dominant 
cytokine generated. 
In summary, we have demonstrated that eosinophil/Fn in- 
teraction results in VLA-4-mediated autocrine generation of 
IL-3 and GM-CSF, which leads to prolongation of eosino- 
phil survival in culture. This could be an important mecha- 
nism for the regulation of eosinophit localization and func- 
tion in health and disease. 
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